Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600121745) titled 'Exploratory Study on SERPINE1 Expression in Peripheral Blood as a Biomarker for Treatment Response and Prognosis in Head and Neck Squamous Cell Carcinoma' on April 2.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Beijing Tongren Hospital, Capital Medical University
Condition:
Head and neck squamous cell carcinoma
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-04-03
Target Sample Size: head and neck squamous cell carcinoma Cohort:80;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=314195
Di...